Our Services

What’s China Focus 

We organize China Focus forums during several major conferences, including BWB week, JPM week, Life Science Summit, Bio International Convention, and many others, to provide an opportunity for specific companies to meet targeted investors and pharma companies.
We help companies to prepare their meetings prior to the conference, and arrange 1-on-1 meetings during these events for the most effective results.

Other Events 

 

MyBioGate also partners with other organizations to provide a platform to those who are seeking Chinese market entry or additional investment sources to meet Chinese investors and explore potential opportunities.
In 2018, we organized Medical Device Innovation and Partnering Forum at the US-China Innovation Summit, and was very well appreciated by both innovative companies and Chinese investors and pharma companies.

Upcoming Events

CHINAFOCUS @ LIFESCIENCE SUMMIT
10.24-10.25, 2018
New York

CHINAFOCUS @ JPM WEEK
1.8-1.11, 2019
San Francisco

CHINAFOCUS @ BWB WEEK
2019
Boston

ONGOING –PITCH ONLINE
Every Other Month
Apply Now!

Why Us

We prepare your pitch packet for investors that is more than a translation of your brief, but a full communication of your technology and vision. The packet facilitates funding and business development for your company and can be provided in non-confidential or confidential versions.  

Our China Focus series attracts investors and big pharma companies that are actively seeking innovative technology and U.S. investment opportunities.  The 1-on-1 meetings during the China Focus forum are the most efficient way to meet Chinese investors.

You may also consider promoting your company by scheduling a CEO Interview with us. The MyBioGate CEO Interview generates direct interest among investors through its storytelling format and helps investors see the full value of the investment opportunity. We interview and feature projects, founding teams, innovators, industry leaders, influencers, and CEOs, for presentation to our audiences in China.